Nerys Woolacott

8.7k total citations · 4 hit papers
99 papers, 6.2k citations indexed

About

Nerys Woolacott is a scholar working on Economics and Econometrics, Rheumatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nerys Woolacott has authored 99 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 17 papers in Rheumatology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nerys Woolacott's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Spondyloarthritis Studies and Treatments (11 papers). Nerys Woolacott is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Spondyloarthritis Studies and Treatments (11 papers). Nerys Woolacott collaborates with scholars based in United Kingdom, Canada and Austria. Nerys Woolacott's co-authors include Alexis Llewellyn, Mark Simmonds, Christopher G. Owen, Mark Corbett, Stephen Rice, Mark Sculpher, Kath Wright, Catriona McDaid, Claire McKenna and Emma Maund and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Clinical Epidemiology and Epilepsia.

In The Last Decade

Nerys Woolacott

99 papers receiving 6.0k citations

Hit Papers

Predicting adult obesity from childhood obesity: a system... 2011 2026 2016 2021 2015 2015 2011 2015 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nerys Woolacott United Kingdom 36 1.8k 1.3k 978 786 694 99 6.2k
Laurie B. Burke United States 26 660 0.4× 884 0.7× 660 0.7× 633 0.8× 655 0.9× 60 5.9k
Wilma M. Hopman Canada 50 1.1k 0.6× 1.7k 1.3× 671 0.7× 464 0.6× 1.0k 1.5× 333 8.7k
Marianne Jensen Hjermstad Norway 48 1.6k 0.9× 1.7k 1.3× 1.7k 1.7× 2.3k 2.9× 604 0.9× 176 9.0k
Philip C Hannaford United Kingdom 45 2.0k 1.1× 459 0.4× 736 0.8× 1.4k 1.7× 1.1k 1.6× 171 7.7k
Jon Håvard Loge Norway 45 1.7k 0.9× 714 0.5× 498 0.5× 2.5k 3.2× 898 1.3× 147 7.5k
Susan Yount United States 32 1000 0.6× 892 0.7× 393 0.4× 1.4k 1.8× 976 1.4× 79 7.8k
Douglas Leslie United States 52 1.3k 0.7× 913 0.7× 519 0.5× 793 1.0× 1.2k 1.7× 283 10.4k
Kelvin P. Jordan United Kingdom 48 1.1k 0.6× 1.9k 1.5× 563 0.6× 408 0.5× 987 1.4× 202 8.7k
Andrew L. Avins United States 40 1.0k 0.6× 921 0.7× 333 0.3× 319 0.4× 937 1.4× 148 7.2k
Neil Scott United Kingdom 43 670 0.4× 2.5k 1.9× 433 0.4× 640 0.8× 527 0.8× 124 6.8k

Countries citing papers authored by Nerys Woolacott

Since Specialization
Citations

This map shows the geographic impact of Nerys Woolacott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nerys Woolacott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nerys Woolacott more than expected).

Fields of papers citing papers by Nerys Woolacott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nerys Woolacott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nerys Woolacott. The network helps show where Nerys Woolacott may publish in the future.

Co-authorship network of co-authors of Nerys Woolacott

This figure shows the co-authorship network connecting the top 25 collaborators of Nerys Woolacott. A scholar is included among the top collaborators of Nerys Woolacott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nerys Woolacott. Nerys Woolacott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wade, Ros, Alexis Llewellyn, Julie Jones-Diette, et al.. (2018). Interventional management of hyperhidrosis in secondary care: a systematic review. British Journal of Dermatology. 179(3). 599–608. 20 indexed citations
2.
Duarte, Ana, Teumzghi F Mebrahtu, Pedro Saramago, et al.. (2017). Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation. Health Technology Assessment. 21(64). 1–244. 23 indexed citations
3.
Corbett, Mark, Mousumi Biswas, Thirimon Moe‐Byrne, et al.. (2017). Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation. Health Technology Assessment. 21(56). 1–326. 32 indexed citations
4.
Wade, Ros, Fiona Paton, & Nerys Woolacott. (2017). Surgical patients' adherence to the use of compression stockings. Nursing times. 113(4). 32–33. 3 indexed citations
5.
Wade, Ros, Stephen Rice, Alexis Llewellyn, et al.. (2017). Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis. Health Technology Assessment. 21(80). 1–280. 11 indexed citations
7.
Hinde, Sebastian, Ros Wade, Stephen Palmer, Nerys Woolacott, & Eldon Spackman. (2016). Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence. PharmacoEconomics. 34(6). 587–596. 2 indexed citations
8.
Carroll, Christopher, Eva Kaltenthaler, Paul Tappenden, et al.. (2016). The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process. Value in Health. 19(7). A468–A469. 1 indexed citations
9.
Wade, Ros, Micah Rose, Aileen Neilson, et al.. (2013). Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal. PharmacoEconomics. 31(10). 841–852. 13 indexed citations
10.
McKenna, Claire, Simon Walker, Paula Lorgelly, et al.. (2012). Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure. Value in Health. 15(3). 420–428. 14 indexed citations
12.
Yang, Huiqin, Dawn Craig, David Epstein, et al.. (2012). Golimumab for the Treatment of Psoriatic Arthritis. PharmacoEconomics. 30(4). 257–270. 27 indexed citations
13.
Maund, Emma, Catriona McDaid, Stephen Rice, et al.. (2011). Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. British Journal of Anaesthesia. 106(3). 292–297. 362 indexed citations breakdown →
14.
Rodgers, Mark, D. Epstein, Laura Bojke, et al.. (2011). Sequential use of biologic therapy. 1 indexed citations
15.
McKenna, Claire, Jane Burch, S Suekarran, et al.. (2010). A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. Health Technology Assessment. 14(24). 1–162. 41 indexed citations
16.
Chambers, Duncan, Debra Fayter, Fiona Paton, & Nerys Woolacott. (2009). Use of Non-randomised Evidence Alongside Randomised Trials in a Systematic Review of Endovascular Aneurysm Repair: Strengths and Limitations. European Journal of Vascular and Endovascular Surgery. 39(1). 26–34. 5 indexed citations
17.
McKenna, Claire, Catriona McDaid, S Suekarran, et al.. (2009). Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis. Health Technology Assessment. 13(24). iii–iv, ix. 44 indexed citations
18.
Burch, Jane, David Epstein, Helen Weatherly, et al.. (2008). Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technology Assessment. 12(8). iii–iv, ix. 60 indexed citations
19.
Rodgers, Mark, Claire McKenna, Stephen Palmer, et al.. (2008). Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technology Assessment. 12(34). iii–iv, xi. 57 indexed citations
20.
Woolacott, Nerys, Neil Hawkins, Anne Mason, et al.. (2006). Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health Technology Assessment. 10(46). 1–233, i. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026